- Home
- EXEL vs TMQ Comparison
EXEL vs TMQ Comparison
Compare EXEL & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | TMQ |
|---|---|---|
| Founded | 1994 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 249.6M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | TMQ |
|---|---|---|
| Price | $46.01 | $4.73 |
| Analyst Decision | Buy | |
| Analyst Count | 24 | 0 |
| Target Price | ★ $45.18 | N/A |
| AVG Volume (30 Days) | 2.8M | ★ 4.4M |
| Earning Date | 02-10-2026 | 09-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.55 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $2,288,218,000.00 | N/A |
| Revenue This Year | $9.84 | N/A |
| Revenue Next Year | $11.92 | N/A |
| P/E Ratio | $18.64 | ★ N/A |
| Revenue Growth | ★ 9.93 | N/A |
| 52 Week Low | $31.90 | $1.06 |
| 52 Week High | $49.62 | $11.29 |
Technical Indicators
Market Signals| Indicator | EXEL | TMQ |
|---|---|---|
| Relative Strength Index (RSI) | 68.79 | 57.28 |
| Support Level | $40.83 | $4.28 |
| Resistance Level | $42.09 | $4.78 |
| Average True Range (ATR) | 1.23 | 0.34 |
| MACD | 0.19 | 0.02 |
| Stochastic Oscillator | 99.02 | 71.83 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.